** Shares of drug distributor Cardinal Health CAH.N rise 2.7% to $208.1 premarket
** CAH forecasts 2026 adjusted profit to be at least $10 per share, compared with its prior range of $9.65 to $9.85 per share
** Analysts expect annual profit of $9.83 per share - data compiled by LSEG
** Company also expects revenue from specialty medicines to surpass $50 billion this year
** "The commentary on scaling specialty to $50 billion in spend by the end of FY26 is another example of how well CAH has been able to drive growth in the areas of the market that are seeing the most growth while also playing catch-up to peers," says Leerink Partners analyst Michael Cherny
** Shares up 73.8% in 2025
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))